Identification of Residues in Transmembrane Regions III and VI That Contribute to the Ligand Binding Site of the Serotonin 5-HT6 Receptor
Overview
Authors
Affiliations
We have examined the ligand binding site of the serotonin 5-HT6 receptor using site-directed mutagenesis. Replacing the highly conserved Asp106 in transmembrane region III by asparagine eliminated D-[3H]-lysergic acid diethylamide ([3H]LSD) binding to the mutant receptor transiently expressed in HEK293 cells. The potency of 5-HT and LSD to stimulate adenylyl cyclase was reduced by 3,600- and 500-fold, respectively, suggesting that an ionic interaction between the positively charged amino group of 5-HT and D106 is essential for high-affinity binding and important for receptor activation. In addition, basal cyclic AMP levels in cells expressing this mutant were increased. Mutation of a tryptophan residue one helix turn toward the extracellular side of transmembrane region III (Trp102) to phenylalanine produced significant changes in the binding affinity and potency of several ligands, consistent with a role of this residue in the formation of the ligand binding site. The exchange of two neighboring residues in the carboxy-terminal half of transmembrane region VI (Ala287 and Asn288) for leucine and serine resulted in a mutant receptor with increased affinities (seven- to 30-fold) for sumatriptan and several ergopeptine ligands. The identification of these interactions will help to improve models of the 5-HT6 receptor ligand binding site.
Pyka P, Haberek W, Wiecek M, Szymanska E, Ali W, Cios A J Med Chem. 2024; 67(2):1580-1610.
PMID: 38190615 PMC: 10823479. DOI: 10.1021/acs.jmedchem.3c02148.
Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.
Myslivecek J Life (Basel). 2022; 12(5).
PMID: 35629274 PMC: 9147915. DOI: 10.3390/life12050606.
Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2.
Podlewska S, Bugno R, Lacivita E, Leopoldo M, Bojarski A, Handzlik J Int J Mol Sci. 2021; 22(3).
PMID: 33494248 PMC: 7864501. DOI: 10.3390/ijms22031035.
Lesiak A, Brodsky M, Cohenca N, Croicu A, Neumaier J Mol Pharmacol. 2018; 94(1):731-742.
PMID: 29678909 PMC: 5987994. DOI: 10.1124/mol.117.111583.
Chen P, Chen P, Li T, Shen Q, Yan D, Zhang L Sci Rep. 2017; 7(1):6848.
PMID: 28754962 PMC: 5533763. DOI: 10.1038/s41598-017-07055-5.